Patent · US Active

Combination therapy

US7919484B2 · kind B2 · utility

9Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 8, 2006
Grant dateApr 5, 2011
Priority date—
Expiry dateNov 14, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is directed to the use of SCD-1 inhibitors of the formula (I): where x, y, V, W, G, J, L, M, R2, R3, R5, R5a, R6, R6a, R7, R7a, R8 and R8a are defined herein, in combination with other drug therapies to treat adverse weight gain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.